HighTide Therapeutics Inc (2511.HK)
HKD 1.8
(5.88%)
HKD 1.8
(5.88%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -368.95 Million | -196.68 Million | -108.33 Million |
| Net Income | -1.03 Billion | -221.22 Million | -266.52 Million |
| Depreciation & Amortization | 2.02 Million | 1.48 Million | 1.91 Million |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 93.49 Million | 25.62 Million | 7.3 Million |
| Change in working capital | -14.12 Million | 28.82 Million | 16.06 Million |
| Other non-cash items | 675.38 Million | -20.95 Million | 145.02 Million |
| Investing Cash Flow | 323.07 Million | -487.48 Million | 752.05 Thousand |
| Investments in PPE | -885.1 Thousand | -212.8 Thousand | -2.1 Million |
| Acquisitions | - | - | 3615.63 |
| Investment purchases | -417.62 Million | -492.96 Million | -1.54 Billion |
| Sales/Maturities of investments | 744.37 Million | 5.68 Million | 2.85 Million |
| Other Investing Activities | -2.78 Million | - | - |
| Financing Cash Flow | 399.3 Million | 53.88 Million | 595.72 Million |
| Debt repayment | -5.13 Million | -1.33 Million | -619.07 Million |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | -582.6 Thousand | -19.53 Million |
| Common Stock Issuance | 436.31 Million | 54.8 Million | - |
| Other Financing Activities | -30.63 Million | -524.45 Thousand | -2.28 Million |
| Accounts receivables | - | - | - |
| Accounts payables | 9.73 Million | 18.15 Million | -977.42 Thousand |
| Inventory | - | - | - |
| Other working capital | -23.85 Million | 10.67 Million | 17.03 Million |
| Cash at beginning of period | 462.95 Million | 936.15 Million | 367.25 Million |
| Cash at end of period | 669.64 Million | 462.95 Million | 936.15 Million |
| Capital Expenditure | -885.1 Thousand | -212.8 Thousand | -2.1 Million |
| Effect of forex changes on cash | 15.32 Million | 49.76 Million | -6.98 Million |
| Net cash flow / Change in cash | 206.69 Million | -473.2 Million | 568.9 Million |
| Free Cash Flow | -369.84 Million | -196.89 Million | -110.44 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -113.33 Thousand | -114.3 Thousand | -1.03 Billion | -214.28 Thousand | -208.91 Thousand | -621.73 Million |
| Depreciation & Amortization | 1550.01 | 1563.36 | 2.02 Million | 556.67 | 542.71 | 923.98 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 29.03 Thousand | 29.28 Thousand | 93.49 Million | 35.78 Thousand | 34.88 Thousand | - |
| Change in working capital | -12.19 Thousand | -12.29 Thousand | -14.12 Million | -3486.88 | -3399.47 | -8.13 Million |
| Other non-cash items | -3648.11 | -3680.12 | 675.38 Million | 63.71 Thousand | 62.11 Thousand | 474.32 Million |
| Investing Cash Flow | -71.01 Thousand | -71.62 Thousand | 323.07 Million | 25.09 Thousand | 24.46 Thousand | 290.97 Million |
| Investments in PPE | -27.40 | -27.64 | -885.1 Thousand | -401.00 | -390.95 | -81.42 Thousand |
| Acquisitions | 133.28 Thousand | - | - | - | - | - |
| Investment purchases | -155.05 Million | - | -417.62 Million | -149.36 Million | - | -258.93 Million |
| Sales/Maturities of investments | - | - | 744.37 Million | 177.75 Million | - | 550 Million |
| Other Investing Activities | -70.98 Thousand | -71.59 Thousand | -2.78 Million | 25.49 Thousand | 24.85 Thousand | - |
| Financing Cash Flow | -3035.54 | -3061.70 | 399.3 Million | 199.7 Thousand | 194.69 Thousand | -2.04 Million |
| Debt repayment | -3.79 Million | - | -5.13 Million | -4.85 Million | - | -169.64 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 436.31 Million | 426.57 Million | - | - |
| Other Financing Activities | -3035.54 | -3061.70 | -30.63 Million | 199.7 Thousand | 194.69 Thousand | -1.3 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 8.92 Million | - | 9.73 Million | 408.04 Thousand | - | 9.1 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -12.19 Thousand | -12.29 Thousand | -23.85 Million | -3486.88 | -3399.47 | -17.24 Million |
| Cash at beginning of period | 669.64 Million | - | 462.95 Million | 606.75 Million | 451.32 Thousand | 462.95 Million |
| Cash at end of period | 421.63 Million | -171.24 Thousand | 669.64 Million | 669.64 Million | 553.38 Thousand | 606.75 Million |
| Capital Expenditure | -27.40 | -27.64 | -885.1 Thousand | -401.00 | -390.95 | -81.42 Thousand |
| Effect of forex changes on cash | 2854.48 | 2879.08 | 15.32 Million | -2391.69 | -2331.74 | - |
| Net cash flow / Change in cash | -248.01 Million | -171.24 Thousand | 206.69 Million | 62.89 Million | 102.06 Thousand | 143.8 Million |
| Free Cash Flow | -98.61 Thousand | -99.46 Thousand | -369.84 Million | -118.12 Thousand | -115.15 Thousand | -147.44 Million |
MLEDR
300706
SEGXF
FSTJ
600006
EXO